AB Science

About:

AB Science is a pharmaceutical company specializing in drugs use tyrosine kinase inhibitors.

Top Investors: European Investment Bank

Description:

AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. They are innovators and scientific entrepreneurs in the field of life science.

Total Funding Amount:

$45.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2001-01-01

Contact Email:

contact(AT)ab-science.com

Founders:

Alain Moussy, Jean-Pierre Kinet

Number of Employees:

101-250

Last Funding Date:

2024-09-30

IPO Status:

Public

Industries: